Table 6: Comparison of MPV, MPV/Pc according to AJCC prognostic staging with another study.
Parameter |
|
Number of cases |
Present study |
p-value |
Number of cases |
Wu YY, et al. [8] |
p-value |
|
MPV/Pc |
AJCC stage |
I/II |
45 |
0.0216 ± 0.0082 |
0.07 |
92 |
0.0311 ± 0.0089 |
0.021 |
III/IV |
36 |
0.0246 ± 0.0101 |
94 |
0.0349 ± 0.0129 |
||||
Lymph node metastasis |
Absent |
43 |
0.0236 ± 0.0080 |
0.07 |
93 |
0.0308 ± 0.0088 |
0.009 |
|
Present |
35 |
0.0248 ± 0.0102 |
93 |
0.0351 ± 0.0129 |
||||
MPV |
AJCC stage |
I/II |
45 |
8.42 ± 1.26 |
0.02 |
92 |
8.37 ± 1.11 |
0.16 |
III/IV |
36 |
9.22 ± 2.33 |
94 |
8.59 ± 1.08 |
||||
Lymph node metastasis |
Absent |
43 |
8.63 ± 1.28 |
0.03 |
93 |
8.37 ± 1.10 |
0.16 |
|
Present |
35 |
9.22 ± 2.37 |
93 |
8.59 ± 1.08 |